Medical News

RSS

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences

The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.

18 Mar 2010

Forensic high-tech assistant Virtobot used to perform virtual autopsies

Virtobot is the name of the forensic high-tech helpmate used at the University of Bern's Institute of Forensic Medicine to perform virtual autopsies. Developed as part of the National Centre of Competence in Research, Co-Me the industrial robot provides forensic doctors with a high precision, three-dimensional image of cadavers.

18 Mar 2010

Teva Pharmaceutical Industries to acquire ratiopharm for €3.625 billion

Teva Pharmaceutical Industries Ltd. announced today that it has entered into a definitive agreement to acquire ratiopharm, Germany’s second largest generics producer and the sixth largest generic drug company worldwide, for an enterprise value of €3.625 billion. The transaction is subject to certain conditions including relevant regulatory approvals. On a pro forma basis, the combined company would have had 2009 revenues of $16.2 billion. Teva expects to complete the transaction by year-end 2010.

18 Mar 2010

Canadian Cancer Society launches daffodil pin campaign to fight back against cancer

The Canadian Cancer Society, BC and Yukon, is stepping up the fight by announcing today the launch of an inaugural daffodil pin - a badge of courage - as part of its annual Daffodil month campaign when canvassers go door-to-door.

18 Mar 2010

Concord Medical Services Holdings reports 24.3% increase in total net revenues for fourth-quarter 2009

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the fourth quarter and fiscal year ended December 31, 2009(1), and the appointment of Dr. Hongbin Cai as an independent board member.

18 Mar 2010

Evaluating functional significance of blockages in cardiac blood vessels with formulas from fluid mechanics

Improved care for cardiac patients and people with coronary artery disease is the goal of a new pilot study being led by engineering and medical researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs (VA) Medical Center.

18 Mar 2010

Researchers find some similarities between SPN and PET

Solid-pseudopapillary neoplasm (SPN) of the pancreas is relatively rare. There are some similarities between SPN and pancreatic endocrine tumor (PET), especially the non-functioning ones, in clinical and pathological manifestations.

18 Mar 2010

First Edition: March 18, 2010

Today's headlines indicate that Democrats are inching closer to securing the votes necessary to pass their health bill while the GOP is planning steps to bottle neck the measure's progress.

18 Mar 2010

Therapeutic may not be effective on trauma patients with undiagnosed Helicobacter infections

A Kansas State University study aimed at alleviating intestinal damage in trauma patients digressed to an important finding that could affect medication given to the individuals.

18 Mar 2010

Study finds the cost of cancer care is skyrocketing

USA Today: "The cost of cancer treatment is 'skyrocketing' — both for individual patients and the nation, a new analysis shows. From 1990 to 2008, spending on cancer care soared to more than $90 billion from $27 billion. The increase was driven by the rising costs of sophisticated new drugs, robotic surgeries and radiation techniques, as well as the growing number of patients who are eligible to take them, says Peter Bach of New York's Memorial Sloan-Kettering Cancer Cancer, co-author of an analysis in today's Journal of the American Medical Association.

18 Mar 2010

APCER Pharma to manage pharmacovigilance strategies for six global pharmaceutical companies

APCER Pharma announced that in the past three months it has further expanded its customer base and operations. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

18 Mar 2010

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.

18 Mar 2010

U.S. 'race gap' in the commission of violent crime has narrowed, yet persists in many cities: Study

The U.S. 'race gap' in the commission of violent crime has narrowed substantially, yet persists in many cities - with murder arrest rates for African Americans out-distancing those for whites - concludes a new 80-city study by the University of Maryland, Florida State University and the University of Oregon.

18 Mar 2010

BeaconEquity.com: AVI BioPharma's revenues for fourth-quarter of 2009 are $5.1M

BeaconEquity.com announces an investment report featuring biotech company AVI BioPharma Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

18 Mar 2010

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

The Health IT Now! Coalition hosted a panel discussion today with the Federal Communications Commission and a panel of experts to discuss the FCC's National Broadband Plan and its proposals to develop affordable access to broadband and healthcare.

18 Mar 2010

Midroog rates Elbit Imaging's new series of debentures "A2/Stable"

Elbit Imaging Ltd.announced today that Midroog Ltd., an affiliate of Moody's Investors Services, has informed EI that its "A2/Stable" rating, on a local scale, would also apply to a new series of debentures in an aggregate principal amount of up to NIS 100 million that EI may issue to repay principal amounts of debt that comes due in 2010. This credit rating would also apply to additional debentures in the new series in an aggregate principal amount of up to NIS 400 million that EI may issue in exchange for outstanding debentures, subject to certain conditions.

18 Mar 2010

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.

18 Mar 2010

ISR Reports launches new and substantial research report: Late Phase Market Dynamics

Industry Standard Research today announced the launch of a new and substantial research report titled Late Phase Market Dynamics. This report presents data and analysis from 149 interviews with decision makers from 95 unique pharmaceutical and biotechnology companies around the world.

18 Mar 2010

Modulating body's inflammatory response may help fight serious infection

Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.

18 Mar 2010

New book exposes the ignored causes of three major life-threatening and chronic diseases

In his newest book, "Overlooked Causes and the Prevention: Cancer, Cardiovascular Heart Disease, Multiple Sclerosis" (published by AuthorHouse), author Arthur Douglass Alexander III exposes, delineates and documents the sometimes overlooked and often ignored causes of three major life-threatening and chronic diseases: cancer, cardiovascular disease and multiple sclerosis.

18 Mar 2010

Medical News

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences

Forensic high-tech assistant Virtobot used to perform virtual autopsies

Teva Pharmaceutical Industries to acquire ratiopharm for €3.625 billion

Canadian Cancer Society launches daffodil pin campaign to fight back against cancer

Concord Medical Services Holdings reports 24.3% increase in total net revenues for fourth-quarter 2009

Evaluating functional significance of blockages in cardiac blood vessels with formulas from fluid mechanics

Researchers find some similarities between SPN and PET

First Edition: March 18, 2010

Therapeutic may not be effective on trauma patients with undiagnosed Helicobacter infections

Study finds the cost of cancer care is skyrocketing

APCER Pharma to manage pharmacovigilance strategies for six global pharmaceutical companies

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

U.S. 'race gap' in the commission of violent crime has narrowed, yet persists in many cities: Study

BeaconEquity.com: AVI BioPharma's revenues for fourth-quarter of 2009 are $5.1M

Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare

Midroog rates Elbit Imaging's new series of debentures "A2/Stable"

Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series

ISR Reports launches new and substantial research report: Late Phase Market Dynamics

Modulating body's inflammatory response may help fight serious infection

New book exposes the ignored causes of three major life-threatening and chronic diseases

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News